Evidence map›Paper›PMID 29085163›Full record

ArticleRadiologia brasileira

Impact of the integration of proton magnetic resonance imaging spectroscopy to PI-RADS 2 for prediction of high grade and high stage prostate cancer.

Michael S Leapman, Zhen J Wang, Spencer C Behr, John Kurhanewicz, Ronald J Zagoria, Peter R Carroll, Antonio C Westphalen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Radiologia brasileira. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Clinical application and progress of quantitative functional magnetic resonance imaging in prostate cancer.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2021
    Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michael S LeapmanMD, Department of Urology, University of California San Francisco, San Francisco, CA, USA.
Zhen J WangMD, Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA.
Spencer C BehrMD, Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA.
John KurhanewiczPhD, Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA.
Ronald J ZagoriaMD, Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA.
Peter R CarrollMPH, MD, Department of Urology, University of California San Francisco, San Francisco, CA, USA.
Antonio C WestphalenMD, PhD, Department of Radiology and Biomedical Imaging and Department of Urology, University of California San Francisco, San Francisco, CA, USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Translation and Evaluation of a Multiparametric Prostate Cancer 3T ExamR01CA137207 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HURD, RALPH EUGENE, KURHANEWICZ, JOHN · 2010 to 2014
$2.6M
NCATS NIH HHS UL1 TR001863NCI NIH HHS R01 CA137207
6 · The paper itself

Abstract

objectiveTo compare the predictions of dominant Gleason pattern ≥ 4 or non-organ confined disease with Prostate Imaging Reporting and Data System (PI-RADS v2) with or without proton magnetic resonance spectroscopic imaging ( MATERIALS AND

methodsThirty-nine men underwent 3-tesla endorectal multiparametric MRI including

resultsThe sensitivity and specificity of

conclusion

Indexed as

DiagnosisMRIProstate cancerProstatectomySpectroscopy

Identifiers

PMID29085163
PMCPMC5656070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.